IFNG and renal cell adenocarcinoma: To determine whether inhibition of IDO attenuates the kynurenine pathway in RCC cells in vitro, and as a prelude to in vivo studies, we evaluated the dose-response of the kynurenine pathway to IFNγ which, of the two IFNs, evoked the higher induction of IDO1.